MedTrace Logo

SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®

NCT01956448 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2800

Last updated 2013-10-08

No results posted yet for this study

Summary

To perform a randomized comparison between the BioMatrix Flex™ and the Resolute Integrity® stents in the treatment of unselected patients with ischemic heart disease.

Conditions

Interventions

DEVICE

Drug eluting stent

Device: Percutaneous intervention with implantation of drug eluting coronary stent (Resolute Integrity)

Sponsors & Collaborators

  • Biosensors International

    collaborator OTHER

  • Medtronic Cardiovascular

    collaborator INDUSTRY

  • Aarhus University Hospital Skejby

    lead OTHER

Principal Investigators

  • Jan Ravkilde, MD · Aalborg University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01956448 on ClinicalTrials.gov